Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Naturlose (D-Tagatose) Efficacy Evaluation Trial

ClinicalTrials.gov ID: NCT00955747

Public ClinicalTrials.gov record NCT00955747. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 11:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Effects of Naturlose (Tagatose) on Glycemic Control and Safety of Naturlose Over One Year in Subjects With Type 2 Diabetes Under Diet Control and Exercise

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this trial was to evaluate the effectiveness and safety of Naturlose (Tagatose) for glycemic control in people with Type 2 diabetes who were not taking other medications for the condition and who were under diet control and exercise. The study lasted approximately one year. HbA1c was monitored every 2 months after entry into the study. Safety and tolerance for tagatose were assessed every 2 months throughout the study. A total of 14 visits were made to the study site.

Study identification

NCT ID
NCT00955747
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Robert Lodder
Industry
Enrollment
494 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2007 (Type not available)
Primary completion
Oct 2010 (Actual)
Completion
Oct 2010 (Actual)
Last update posted
Nov 19, 2014

2007 – 2010

United States locations

U.S. sites
21
U.S. states
12
U.S. cities
21
Facility City State ZIP Site status
Simon Williamson Clinc Hueytown Alabama 35023 —
Medical Affiliated Research Center Huntsville Alabama 35801 —
NEA Clinical-Research Solutions Jonesboro Arkansas 72404 —
Alia Clinical Research Huntington Park California 90255 —
Atlanta Primary Care Center Atlanta Georgia 30312 —
River Birch Research Alliance Blue Ridge Georgia 30513 —
Affinity Healthcare Arlington Heights Illinois 60004 —
John Stroger Cook County Hospital Chicago Illinois 60612 —
University of Kentucky Lexington Kentucky 40502 —
Activmed Practices and Research Haverhill Massachusetts 01830 —
Nevada Alliance Against Diabetes Las Vegas Nevada 89101 —
Ocean County Clinical Research Brick New Jersey 08724 —
Cedar Clinical Research Oradell New Jersey 07649 —
Hamilton Clinical Research Trenton New Jersey 08690 —
ReSevo, LLC Cuyahoga Falls Ohio 44223 —
Capital Medical Clinic Austin Texas 78705 —
TTS Research/Hill Country Medical Boerne Texas 78006 —
Galenos Research Dallas Texas 75251 —
Century Clinical Research Houston Texas 77036 —
Cetero Research San Antonio Texas 78229 —
Optimum Clinical Research Salt Lake City Utah 84102 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00955747, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 19, 2014 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00955747 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →